Interference of circulating endogenous antibodies on the Dimension® DGNA digoxin immunoassay: Elimination with a heterophilic blocking reagent

Clinical Biochemistry

Volumn 43, Issue 18, 2010, Pages 1475-1477

  Hermida Cadahía, Esperanza F ^a   Calvo, M Mar ^a   Tutor, J Carlos ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Circulating endogenous antibodies interference; Digoxin; Dimension DGNA immunoassay

Indexed keywords

ANTIBODY; DIGOXIN; HETEROPHILE ANTIBODY;

ACUTE RESPIRATORY FAILURE; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CASE REPORT; CYANOSIS; DIGOXIN IMMUNOASSAY; DRUG BLOOD LEVEL; DRUG MONITORING; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCAPNIA; IMMUNOASSAY; LUNG EXAMINATION; MALE; PERICARDIAL EFFUSION; PNEUMONIA; PRIORITY JOURNAL; STEADY STATE;

AGED; ANIMALS; ANTIBODIES, HETEROPHILE; CATS; DIGOXIN; DOGS; HUMANS; IMMUNOASSAY; MALE; RABBITS;

EID: 78149499228     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.09.018     Document Type: Article

References (15)

1. Rogers N.M., Jones T.E., Morris R.G. Frequently discordant results from therapeutic drug monitoring for digoxin: clinical confusion for the prescriber. Intern Med J 2010, 40:52-56.
2. Cobo A., Martin-Suarez A., Calvo M.V., Dominguez-Gil A., Fernández de Gata M.M. Clinical repercusions of analytical interferentes due to aldosterone antogonists in digoxina immunoassays: an assessment. Ther Drug Monit 2010, 32:169-176.
3. Dasgupta A. Endogenous and exogenous digoxin-like immunoreactive substances. Am J Clin Pathol 2002, 118:132-140.
4. Wu S.L., Li W., Wells A., Dasgupta A. Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations. Am J Clin Pathol 2001, 115:600-604.
5. Berendes E., Cullen P., Van Aken H., Zidek W., Erren M., Hübschen M., et al. Endogenous glycosides in critically ill patients. Crit Care Med 2003, 31:1331-1337.
6. Morris R.G., Jones T.E., Goldsworthy S.J., Wagner T.J., Ho H., Horowitz J.D. Suspected DLIS interference in the Dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range. Ther Drug Monit 2006, 28:454-457.
7. Ismail A.A.A., Walker P.L., Cawod M.L., Barth J.H. Interference in immunoassays is an underestimated problem. Ann Clin Biochem 2002, 39:366-373.
8. Ismail A.A.A. On the detecting interference from endogenous antibodies in immunoassays by doubling dilutions test. Clin Chem Lab Med 2007, 45:851-854.
9. Ismail Y., Imail A.A., Ismail A.A.A. Erroneous laboratory results: what clinicians need to kcnow. Clin Med 2007, 7:357-361.
10. Liendo C., Ghali J.K., Graves S.W. A new interference in some digoxin assays: anti-murine heterophilic antibodies. Clin Pharmacol Ther 1996, 60:593-598.
11. Rangan I.M., Morfin J.P., Willians S.R., Clark R.F. Falsely elevated digoxin levels of 45.9ng/mL due to interference from human antimouse antibody. J Toxicol Clin Toxicol 2000, 38:343-345.
12. Eksborg S. Evaluation of method-comparison. Clin Chem 1981, 27:1311-1312.
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:87-94.
14. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., McGilveray I.J., et al. Bioanalytical method validation. A revisit with a decade of progress. Pharm Res 2000, 17:1551-1557.
15. Kaplan I.V., Levinson S.S. When is a heterophile antibody not a heterophile antibody? When is an antibody against a specific immunogen. Clin Chem 1999, 45:616-618.